Balchem Corporation (BCPC)
Largest Insider Buys in Sector
BCPC Stock Price History Chart
BCPC Stock Performance
About Balchem Corporation
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and …
Insider Activity of Balchem Corporation
Over the last 12 months, insiders at Balchem Corporation have bought $0 and sold $20.77M worth of Balchem Corporation stock.
On average, over the past 5 years, insiders at Balchem Corporation have bought $0 and sold $5.11M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 3,000 shares for transaction amount of $254,220 was made by MASON SCOTT C (Vice President) on 2019‑08‑05.
List of Insider Buy and Sell Transactions, Balchem Corporation
| 2024-07-31 | Sale | SVP and GM, Specialty Products | 7,750 0.0242% | $180.05 | $1.4M | -1.28% | ||
| 2024-07-30 | Sale | VP & Chief Accounting Officer | 4,804 0.0149% | $178.93 | $859,560 | 0.00% | ||
| 2024-05-10 | Sale | SVP & Chief Technology Officer | 1,929 0.0059% | $154.45 | $297,935 | +8.59% | ||
| 2024-05-08 | Sale | director | 5,000 0.0154% | $152.98 | $764,902 | +10.78% | ||
| 2024-03-08 | Sale | SVP & Chief HR Officer | 5,339 0.0166% | $157.52 | $840,985 | +0.33% | ||
| 2024-03-04 | Sale | director | 1,333 0.0041% | $156.89 | $209,128 | -0.20% | ||
| 2024-02-26 | Sale | VP & Chief Accounting Officer | 7,000 0.0217% | $155.19 | $1.09M | +0.83% | ||
| 2024-02-23 | Sale | VP & Chief Accounting Officer | 9,180 0.0284% | $156.37 | $1.44M | -0.13% | ||
| 2024-02-22 | Sale | Chairman, President & CEO | 34,350 0.1059% | $154.29 | $5.3M | +0.93% | ||
| 2024-02-21 | Sale | Chairman, President & CEO | 29,679 0.0924% | $153.58 | $4.56M | +1.96% | ||
| 2024-02-21 | Sale | VP & Chief Accounting Officer | 15,000 0.047% | $154.74 | $2.32M | +1.96% | ||
| 2024-02-21 | Sale | SVP & Chief Technology Officer | 11,100 0.0345% | $153.21 | $1.7M | +1.96% | ||
| 2023-09-11 | Sale | director | 3,800 0.0117% | $131.57 | $499,979 | +10.58% | ||
| 2023-05-02 | Sale | SVP & Chief Technology Officer | 2,300 0.0071% | $130.36 | $299,837 | +3.29% | ||
| 2022-08-12 | Sale | Vice President | 1,000 0.0031% | $131.12 | $131,121 | -2.34% | ||
| 2022-08-05 | Sale | Vice President | 2,629 0.0082% | $127.01 | $333,904 | +2.35% | ||
| 2022-08-03 | Sale | Vice President | 1,401 0.0043% | $125.02 | $175,148 | +3.58% | ||
| 2021-08-09 | Sale | Chief Accounting Officer | 10,520 0.0329% | $132.02 | $1.39M | +5.87% | ||
| 2021-08-06 | Sale | Chief Accounting Officer | 12,248 0.0381% | $134.04 | $1.64M | +3.74% | ||
| 2020-11-13 | Sale | Vice President | 3,000 0.009% | $103.00 | $309,000 | +23.20% |
Insider Historical Profitability
| FITZPATRICK FRANK | Vice President Administration | 73191 0.2251% | $179.93 | 1 | 37 | <0.0001% |
| WEDRAL ELAINE R | director | 29697 0.0914% | $179.93 | 1 | 11 | <0.0001% |
| TELEVANTOS JOHN Y | director | 28326 0.0871% | $179.93 | 1 | 7 | <0.0001% |
| Premdas Perry W | director | 13950 0.0429% | $179.93 | 1 | 0 | +2.8% |
| COOMBS PAUL D | director | 11494 0.0354% | $179.93 | 2 | 0 | +37.54% |
Institutional Investor Ownership
| BlackRock | $766.44M | 15.26 | 4.95M | -0.86% | -$6.66M | 0.02 | |
| The Vanguard Group | $609.87M | 12.14 | 3.94M | +3.81% | +$22.38M | 0.01 | |
| APG Asset Management | $435.78M | 9.37 | 3.04M | +4.74% | +$19.71M | 0.76 | |
| Wasatch Advisors | $291.59M | 5.8 | 1.88M | -1.5% | -$4.43M | 1.53 | |
| State Street | $190.46M | 3.79 | 1.23M | +1.37% | +$2.57M | 0.01 |